Magali Haas, M.D., Ph.D., M.S.E.,is CEO and President of Cohen Veterans Bioscience, a non-profit brain research organization based in Cambridge, MA. Cohen Veterans Bioscience was established as a joint initiative between Orion Bionetworks, Inc. and Steve A. Cohen to advance the detection and treatment of post-traumatic stress (PTS) and traumatic brain injury (TBI) and related co-morbidities through cutting-edge research, so that the burden of these conditions may be lessened on service members, veterans, and their families. Orion Bionetworks was founded in 2012 by Dr. Haas to accelerate the development of next-generation diagnostics and treatments for brain disorders by harnessing the power of biotechnology (including neuroimaging, ‘omics, and biosensors) in combination with high-performance computing and data analytics, to understand the underlying mechanisms of disease and discover new ways to improve brain health.
Magali has over 15 years of pharmaceutical executive and clinical research experience, predominantly at Johnson & Johnson, where she assumed broad end-to-end development leadership roles in medical marketing, full clinical development, early development, and translational and biomarker sciences in psychiatry and neurology. She successfully filed NDAs in the US and Europe for risperidone indications in Autism, Adolescent Schizophrenia, Juvenile Bipolar Disorder and Conduct Disorders. She also led Development Teams evaluating compounds for Depression, Neuropathic Pain, Epilepsy, and Migraine Disorder.
As an “intrapreneur” at J&J she established the first Neuroscience Translational Medicine & Integrative Solutions department, and co-founded the first Companion Diagnostics Center of Excellence as well as an R&D Innovation team. She serves on several advisory boards including the Alzheimer’s Association National Plan Milestone Workgroup, Brain Canada, Pear Therapeutics and IMEC for nanoelectronics. Magali earned her bachelor of science degree in bioengineering from the University of Pennsylvania, a master of science degree in biomedical engineering from Rutgers University, New Jersey, and a medical degree and doctorate in neuroscience from Albert Einstein College of Medicine, New York.